Why do GLP-1 side effects feel worse before your period?

What do GLP-1 drugs do to the gut?

The labels are direct about it. The semaglutide prescribing information states that semaglutide delays gastric emptying, and the tirzepatide label adds that the delay is largest after the first dose and diminishes over time.¹² The most common side effect on both labels is nausea, which the labels report alongside the delayed emptying without asserting one causes the other. Nausea was reported by 44% of people on Wegovy 2.4 mg against 16% on placebo, and by 25% to 29% of people on Zepbound against 8% on placebo.¹²

So the baseline is a gut that is already moving more slowly than it used to. The question is whether the luteal phase slows it further.

Does the luteal phase slow digestion?

Sometimes, depending on what is measured. The clearest finding is for transit from mouth to caecum, the start of the large intestine. In 1981, Wald and colleagues measured how long lactulose took to travel that far in 15 normally menstruating women, once in the follicular phase and once in the luteal phase, and found transit significantly prolonged in the luteal phase, when progesterone is high.³ A 1987 study of 7 women found gastric emptying of solids significantly slower in the luteal phase, and the slowing correlated with serum progesterone.⁴

Studies of the stomach alone are less consistent. A 1985 study of 10 women found no change in gastric emptying of solids or liquids between the two phases.⁵ A 1993 study of 15 women found the same, with half-emptying times of 78 minutes in the follicular phase and 75 in the luteal.⁶ The largest comparison, 50 women in the follicular phase against 50 in the luteal phase, found no differences in gastric emptying of solids, liquids, or indigestible markers.⁷ And a 2009 study of 9 lean women found gastric emptying of a glucose drink slower in the follicular phase, the opposite direction, with lower plasma GLP-1 in that phase too.⁸

Read together, the evidence says that mouth-to-caecum transit slowed in the luteal phase in the one study that measured it, that stomach emptying may or may not, and that the samples are small. Progesterone is the usual suspect because it rises in the luteal phase and because two of the studies found a correlation with it,³⁴ but correlation in a dozen women is not a mechanism.

So is the premenstrual week really worse on a GLP-1?

Nobody has tested it, so the honest answer is that it is plausible and unproven. A drug that slows the gut, layered on a phase that may slow the gut, could reasonably produce more bloating, constipation, or nausea in the days before a period for some women. It could equally be that the premenstrual symptoms many women already have, bloating among them, are being attributed to the drug because the drug is new. The studies above cannot tell those two stories apart, and neither can a label.

What they do suggest is that the answer may be individual. In the largest stomach-emptying study no phase effect appeared on average,⁷ while the mouth-to-caecum study found one.³ An average that hides a mix of responders and non-responders is exactly the kind of question a personal record can answer where a population study cannot.

How can you tell if it is true for you?

By writing the symptom down with its date and severity, next to the dose and next to the period, for two or three cycles, and then looking at the pattern. If the bloating and nausea cluster in the same cycle days each month, that is information your prescriber can use. If they cluster in the days after each dose instead, that is different information. If they cluster nowhere, that is useful too.

Protocol Her records a side effect with a severity from 1, Barely there, to 5, Severe, picked from a fixed set of chips that includes nausea, constipation, diarrhea, bloating, appetite loss, fatigue, headache, dizziness, insomnia, injection pain, injection site reaction, and hair changes, with "Other" requiring a note. Each entry is linked to the most recent dose within the previous 7 days, and when more than one compound was dosed in that window the app asks which one the note belongs to. The app states which dose was recorded with the note; it never states that the dose caused it.

Once periods are logged, the Analytics screen counts side effects by cycle phase over the last 90 days, and the side-effect timeline in the clinician PDF carries a cycle-phase column, so the pattern you are looking for is tabulated rather than remembered. Whether the drug itself changes periods is a separate question, covered in Can semaglutide or tirzepatide affect your period?. The semaglutide guide and the tirzepatide guide cover what each compound is and how the app tracks it.